Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial
Streamline Investigators, Stuart A. Taylor*, Sue Mallett, Simon Ball, Sandy Beare, Gauraang Bhatnagar, Angshu Bhowmik, Peter Boavida, John Bridgewater, Caroline S. Clarke, Marian Duggan, Steve Ellis, Robert Glynne-Jones, Vicky Goh, Ashley M. Groves, Ayshea Hameeduddin, Sam M. Janes, Edward W. Johnston, Dow Mu Koh, Sara LockAnne Miles, Stephen Morris, Alison Morton, Neal Navani, Alfred Oliver, Terry O'Shaughnessy, Anwar R. Padhani, David Prezzi, Shonit Punwani, Laura Quinn, Hameed Rafiee, Krystyna Reczko, Andrea G. Rockall, Peter Russell, Harbir S. Sidhu, Nicola Strickland, Kathryn Tarver, Jonathan Teague, Steve Halligan, Ruth Evans, Khawaja Shahabuddin, Revanth Jannapureddy, Tina Mills-Baldock, Kishor Barhate, Zoltan Nagy, Sherif Raouf, Nathalie Rich, Tuck Kay Loke, Sofia Gourtsoyianni, Christian Kelly-Morland, Abel Jalloh
Research output: Contribution to journal › Article › peer-review
54Citations
(Scopus)
129Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial'. Together they form a unique fingerprint.